Authors: Mie Sara Hestbech, Elsebeth Lynge, Jakob Kragstrup, Volkert Siersma, Miguel Vazquez-Prada Baillet, John Broderson Abstract: Objectives To explore the interplay between primary and secondary prevention of cervical cancer by estimating future screening outcomes in women offered human papillomavirus (HPV) vaccination when they were sexually naïve. Design Estimation of outcome of liquid-based cytology screening for a post-HPV vaccination […]
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase
Authors: Rebecca E. Chandler, Kristina Juhlin, Jonas Fransson, Ola Caster, I. Ralph Edwards, G. Niklas Norén Abstract: Introduction A number of safety signals—complex regional pain syndrome (CRPS), postural orthostatic tachycardia syndrome (POTS), and chronic fatigue syndrome (CFS)—have emerged with human papillomavirus (HPV) vaccines, which share a similar pattern of symptomatology. Previous signal evaluations and epidemiological studies have largely relied on traditional methodologies and signals have been […]
Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination
Immunological studies of cerebrospinal fluid from patients with CNS symptoms after human papillomavirus vaccination Highlights •32 patients with prolonged CNS symptoms after HPV vaccination were studied. •CSF levels of IL-4, IL-13, IL-17, IL-8 and MCP-1 were elevated. •CSF levels of PDGF-bb and IL-12 were decreased. •Antibodies to GluN2B-NT2, GluN2B-CT and GluN1-NT in CSF were increased. […]
Colombia: Will there be HPV Vaccine Suspension?
Vaccine Suspension Translation by Mario Lamos Breaking News: The Attorney General’s Office appealed to the Constitutional Court asking for enforcement of a previous ruling issued by the High Court of Cali, requiring the Ministry of Health to suspend the HPV vaccination program in Colombia. The watchdog said the Constitutional Court must rule on the matter because the side […]
Reduction in HPV Prevalence— No Evidence to Support HPV Vaccination reduces HPV Prevalence
Authors: Jennifer A. Groner1, George D. Harris2 and Diane M. Harper3,4,5 TO THE EDITOR—The recent Centers for Disease Control and Prevention (CDC) study by Markowitz et al [1] provides limited and inconclusive data on 111 sexually active females between 14 and 19 years of age who received at least 1 dose of quadrivalent human papillomavirus vaccine (HPV4). The […]
- 1
- 2
- 3
- …
- 6
- Next Page »
